Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
     L01A ALKYLATING AGENTS
     L01B ANTIMETABOLITES
       L01BA Folic acid analogues
         L01BA01 Methotrexate [DG:DG00681]
           D00142  Methotrexate (JP18/USP/INN) <JP/US>
           D02115  Methotrexate sodium <US>
         L01BA03 Raltitrexed
         L01BA04 Pemetrexed [DG:DG00682]
         L01BA05 Pralatrexate
       L01BB Purine analogues
       L01BC Pyrimidine analogues
     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
     L01E PROTEIN KINASE INHIBITORS
     L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
     L01X OTHER ANTINEOPLASTIC AGENTS
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
     L04A IMMUNOSUPPRESSANTS
       L04AA Selective immunosuppressants
       L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors [DG:DG01936]
       L04AC Interleukin inhibitors [DG:DG02019]
       L04AD Calcineurin inhibitors [DG:DG03129]
       L04AE Sphingosine-1-phosphate (S1P) receptor modulators
       L04AF Janus-associated kinase (JAK) inhibitors
       L04AG Monoclonal antibodies
       L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors
       L04AJ Complement inhibitors
       L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors
       L04AX Other immunosuppressants
         L04AX01 Azathioprine [DG:DG00743]
         L04AX02 Thalidomide
         L04AX03 Methotrexate [DG:DG00681]
           D00142  Methotrexate (JP18/USP/INN) <JP/US>
           D02115  Methotrexate sodium <US>
         L04AX04 Lenalidomide [DG:DG00744]
         L04AX05 Pirfenidone
         L04AX06 Pomalidomide
         L04AX07 Dimethyl fumarate
         L04AX08 Darvadstrocel
         L04AX09 Diroximel fumarate
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 22, 2024
According to WHO's ATC 2024

» Japanese version